- Home
- MLR vs DNA Comparison
MLR vs DNA Comparison
Compare MLR & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLR
- DNA
- Stock Information
- Founded
- MLR 1990
- DNA 2008
- Country
- MLR United States
- DNA United States
- Employees
- MLR N/A
- DNA N/A
- Industry
- MLR Construction/Ag Equipment/Trucks
- DNA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MLR Consumer Discretionary
- DNA Health Care
- Exchange
- MLR Nasdaq
- DNA Nasdaq
- Market Cap
- MLR 455.2M
- DNA 466.4M
- IPO Year
- MLR 1994
- DNA N/A
- Fundamental
- Price
- MLR $47.23
- DNA $8.11
- Analyst Decision
- MLR Strong Buy
- DNA Sell
- Analyst Count
- MLR 1
- DNA 5
- Target Price
- MLR $82.00
- DNA $17.25
- AVG Volume (30 Days)
- MLR 68.7K
- DNA 1.1M
- Earning Date
- MLR 05-07-2025
- DNA 05-06-2025
- Dividend Yield
- MLR 1.69%
- DNA N/A
- EPS Growth
- MLR N/A
- DNA N/A
- EPS
- MLR 4.69
- DNA N/A
- Revenue
- MLR $1,133,280,000.00
- DNA $237,417,000.00
- Revenue This Year
- MLR N/A
- DNA N/A
- Revenue Next Year
- MLR $18.55
- DNA $16.74
- P/E Ratio
- MLR $10.11
- DNA N/A
- Revenue Growth
- MLR N/A
- DNA 13.76
- 52 Week Low
- MLR $37.40
- DNA $5.00
- 52 Week High
- MLR $78.25
- DNA $38.60
- Technical
- Relative Strength Index (RSI)
- MLR 68.56
- DNA 56.32
- Support Level
- MLR $41.78
- DNA $6.42
- Resistance Level
- MLR $47.73
- DNA $8.43
- Average True Range (ATR)
- MLR 1.20
- DNA 0.60
- MACD
- MLR 0.92
- DNA 0.11
- Stochastic Oscillator
- MLR 93.66
- DNA 84.29
About MLR Miller Industries Inc.
Miller Industries Inc is engaged in the manufacturing of vehicle towing and recovery equipment. The company produces wreckers, car carriers, and trailer bodies under the Century, Vulcan, Challenger, Holmes, Champion, Chevron, Eagle, Titan, Jige, and Boniface brands. The products are sold in North America, Canada, and Mexico through independent distributors.
About DNA Ginkgo Bioworks Holdings Inc.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.